In the pivotal clinical trial, the safety and efficacy of desloratadine were evaluated in more than 2,300 patients aged 12 to 75 years with seasonal allergic rhinitis. The agent significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback